 |
|
Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2024;30(2):235-246. Published online 2024 Jan 26 DOI: https://doi.org/10.3350/cmh.2023.0485
|
|
Citations to this article as recorded by
 An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi
Metabolism.2025; 162: 156080. CrossRef Association between skeletal muscle mass to visceral fat area ratio and depression: A cross-sectional study based on the National Health and Nutrition Examination Survey
Chenle Ye, Guangzhan Chen, Weikai Huang, Yuanrun Liu
Journal of Affective Disorders.2025; 372: 314. CrossRef Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver disease
Zobair M. Younossi, J.Michael Estep, Sean Felix, Brian Lam, Zaid Younossi, Andrei Racila, Maria Stepanova
Diabetes Research and Clinical Practice.2025; 219: 111960. CrossRef Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China
Guanghui Ma, Guohou Xu, Haixia Huang
Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis
Jeayeon Park, Goh Eun Chung, Yoosoo Chang, So Eun Kim, Won Sohn, Seungho Ryu, Yunmi Ko, Youngsu Park, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gut and Liver.2025; 19(1): 126. CrossRef Letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
Xiao-Song Li, Xi-Ping Shen, Hang Li
Clinical and Molecular Hepatology.2025; 31(1): e15. CrossRef PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
Baokai Sun, Likun Zhuang
Clinical and Molecular Hepatology.2025; 31(1): e67. CrossRef Metabolic dysfunction-associated steatotic liver disease and the cardiovascular system
Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, Antonis S. Manolis
Trends in Cardiovascular Medicine.2025; 35(4): 258. CrossRef KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
Won Sohn, Young-Sun Lee, Soon Sun Kim, Jung Hee Kim, Young-Joo Jin, Gi-Ae Kim, Pil Soo Sung, Jeong-Ju Yoo, Young Chang, Eun Joo Lee, Hye Won Lee, Miyoung Choi, Su Jong Yu, Young Kul Jung, Byoung Kuk Jang
Clinical and Molecular Hepatology.2025; 31(Suppl): S1. CrossRef Association Between Handgrip Strength and Cardiovascular Disease Risk in MASLD: A Prospective Study From UK Biobank
Tae Seop Lim, Sujin Kwon, Sung A. Bae, Hye Yeon Chon, Seol A. Jang, Ja Kyung Kim, Chul Sik Kim, Seok Won Park, Kyoung Min Kim
Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef Underrepresentation of Asians in diagnostic test development and drug trials in MASLD
Lung-Yi Mak, Terry Cheuk-Fung Yip, Chi-Ho Lee, Jimmy Che-To Lai, Vincent Wai-Sun Wong
Journal of Hepatology.2025;[Epub] CrossRef Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clinical and Molecular Hepatology.2025; 31(Suppl): S182. CrossRef Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”
Jeayeon Park, Su Jong Yu
Clinical and Molecular Hepatology.2025; 31(2): e221. CrossRef Comprehensive Analysis Reveals the Molecular Features and Immune Infiltration of PANoptosis-Related Genes in Metabolic Dysfunction-Associated Steatotic Liver Disease
Yan Huang, Jingyu Qian, Zhengyun Luan, Junling Han, Limin Tang
Biology.2025; 14(5): 518. CrossRef Steatotic liver disease: Know your enemies
Lung-Yi Mak
Clinical and Molecular Hepatology.2024; 30(2): 171. CrossRef Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
Hideki Fujii, Michihiro Iwaki, Yoshihiro Kamada
Clinical and Molecular Hepatology.2024; 30(2): 281. CrossRef In response to: Steatotic liver disease-know your enemies
Michael H. Le, Linda Henry, Mindie H. Nguyen
Clinical and Molecular Hepatology.2024; 30(2): 284. CrossRef Polyphenols and terpenoids derived from Ocimum species as prospective hepatoprotective drug leads: a comprehensive mechanistic review
Amrita Chatterjee, Biswatrish Sarkar
Phytochemistry Reviews.2024;[Epub] CrossRef Treatment of Metabolic Disorders Using Novel DGAT2 Inhibitors: Pyrazolopyridine and Triazolopyridine Derivatives
Robert B. Kargbo
ACS Medicinal Chemistry Letters.2024; 15(8): 1199. CrossRef Fatty acid composition of blood serum and erythrocyte membranes in men with steatosis and steatohepatitis with normal transaminase activity
M. V. Kruchinina, M. F. Osipenko, A. A. Shestov, M. V. Parulikova
Sechenov Medical Journal.2024; 15(2): 48. CrossRef Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions
Lung-Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, Kuo Chao Yew, Nobuharu Tamaki, Ruveena Bhavani Rajaram, Mara Teresa Panlilio, Rashid Lui, Hye Won Lee, Jimmy Che-To Lai, Anand V. Kulkarni, Madhumita Premkumar, Cosmas Rinaldi Adithya Lesmana, Yao Chun Hsu,
Nature Reviews Gastroenterology & Hepatology.2024; 21(12): 834. CrossRef Cross-generational effects of dietary sea buckthorn on non-alcoholic fatty liver disease in offspring of obese female mice
Weipeng Zhang, Yonghua Shi, Yu Wang, Xuan Liu, Jianchen Yan, Haoran Chen, Junxing Zhao
Journal of Functional Foods.2024; 121: 106398. CrossRef An analysis of the burden of liver cirrhosis: Differences between the global, China, the United States and India
Keqiang Lu, Juanjuan Sui, Wenhui Yu, Yan Chen, Zhiyong Hou, Pengyan Li, Yuli Sun
Liver International.2024; 44(12): 3183. CrossRef The Predictive Value of Time‐Varying Noninvasive Scores on Long‐Term Prognosis of NAFLD in South Korea
Sung Won Chung, Min Kyung Park, Xiao Zhang, Tongtong Wang, Thomas Jemielita, Gail Fernandes, Samuel S. Engel, Heejoon Jang, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim, Xingshun Qi
Canadian Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
Clinical and Molecular Hepatology.2024; 30(4): 962. CrossRef Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”
Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
Clinical and Molecular Hepatology.2024; 30(4): 1039. CrossRef PAMK Ameliorates Non-Alcoholic Steatohepatitis and Associated Anxiety/Depression-like Behaviors Through Restoring Gut Microbiota and Metabolites in Mice
Jianmei Yang, Wanyi Ou, Guiru Lin, Yuanfei Wang, Dongliang Chen, Ze Zeng, Zumin Chen, Xiaomin Lu, Aiping Wu, Chenli Lin, Yinji Liang
Nutrients.2024; 16(22): 3837. CrossRef Pathogenesis and management of metabolic dysfunction-associated
steatohepatitis-related hepatocellular carcinoma: a narrative
review
Han Ah Lee
The Ewha Medical Journal.2024;[Epub] CrossRef Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
The Korean Journal of Internal Medicine.2024; 39(6): 931. CrossRef Acetaminophen protein adduct concentrations during therapeutic dosing in patients with class II-III obesity compared to non-obese and overweight patients: a prospective observational gender stratified cohort study
H.A. De Baerdemaeker, P De Cock, L De Baerdemaeker
Acta Anaesthesiologica Belgica.2024; 75(Supplement): 63. CrossRef
|